Almac appoints Kevin Stephens financial director
This article was originally published in Scrip
Almac has promoted Kevin Stephens, who joined the company in 2001, to the position of finance director. Mr Stephens has been Almac's executive vice-president of finance since October 2010.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.